ESC 2010

Stockholm, Sweden; August 28 - September 1

The REALISE-AF registry: an international, observational, cross-sectional survey describing characteristics, cardiovascular risk, and management of patients with atrial fibrillation - P G Steg
- Presentation Slides

Tuesday Meeting Wrap-Up
- CVN Video
The Danish multicenter randomised trial on single lead atrial versus dual chamber pacing in sick sinus syndrome (DANPACE) - J C Nielsen
- Trial Summary
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes (AVERROES) - S J Connolly
- Trial Summary
- Presentation Slides
Oral rivaroxaban versus standard therapy in the initial treatment of symptomatic deep vein thrombosis and long-term prevention of recurrent venous thromboembolism (EINSTEIN DVT) - H Buller
- Trial Summary
Angiotensin II-antagonist in paroxysmal atrial fibrillation trial (ANTIPAF) - A Goette
- Trial Summary
A randomised trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux (FUTURA OASIS 8) - S Jolly

Monday Meeting Wrap-Up
- CVN Video
A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI (INNOVATE PCI) - S Rao
- Trial Summary
- Presentation Slides
A randomised trial to compare survival following bilateral versus single internal mammary (IMA) grafting in coronary revascularisation (ART) - D Taggart
- Trial Summary
- Presentation Slides
Long-term comparison of Everolimus-eluting and Sirolimus-eluting Stents for cOronary revascularisation (LESSON I) - S Windecker
- Presentation Slides
An international, randomized trial comparing i.v. enoxaparin with i.v. unfractionated heparin in primary PCI for ST-elevation myocardial infarction (ATOLL) - G Montalescot
- Trial Summary
- Presentation Slides
J-LANCELOT: Double-blind, placebo-controlled phase II studies of E5555 in Japanese patients with Acute Coronary Syndrome (ACS) and Coronary Artery Disease (CAD) - S Goto
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or with Atherothrombosis: Final Follow-Up from the International REACH Registry - D L Bhatt
- Presentation Slides
- CVN Video

Sunday Meeting Wrap-Up
- CVN Video
Multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart failure patients (PEARL HF) - B Pitt
- Trial Summary
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction (SHIFT) - M Komajda
- Trial Summary
- Presentation Slides
Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients (ALPHA OMEGA) - D Kromhout
A single dose of erythropoietin in ST-elevation myocardial infarction (HEBE III) - A A Voors
- Trial Summary
- Presentation Slides
Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in acute coronary syndrome (PLATO genetic substudy) - L C Wallentin
- Presentation Slides
- CardioSmart for Your Patients
Development of a risk score for transcatheter aortic valve implantation: 1-year outcomes from over 1,000 patients in the source registry (SOURCE REGISTRY TAVI) - O Wendler
- CVN Video
CURE ACTIVE: Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype in over 6000 patients with Non-ST-elevation Acute Coronary Syndromes (CURE trial) and atrial fibrillation (ACTIVE trial) - G Pare
- Presentation Slides
- CVN Video